2005 Josef Warkany lecture: Clinicians
- 1 January 2006
- journal article
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 76 (1) , 1-6
- https://doi.org/10.1002/bdra.20224
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Statin drugs and congenital anomaliesAmerican Journal of Medical Genetics Part A, 2005
- Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statinsAmerican Journal of Medical Genetics Part A, 2004
- Selecting the appropriate rodent diet for endocrine disruptor research and testing studies.ILAR Journal, 2004
- Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs.Drug Safety, 2002
- Periconceptional vitamin a use: How much is teratogenic?Reproductive Toxicology, 1998
- Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancyReproductive Toxicology, 1996
- Bendectin: Review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigenReproductive Toxicology, 1995
- An assessment of lithium using the iehr evaluative process for assessing human developmental and reproductive toxicity of agentsReproductive Toxicology, 1995
- An evaluative process for assessing human reproductive and developmental toxicity of agentsReproductive Toxicology, 1995
- Symposium abstractsTeratology, 1991